Healthcare -
Biotechnology - NASDAQ - US
$ 6.45
-4.02 %
$ 143 M
Market Cap
-2.96
P/E
INMB - CHANGE IN WORKING CAPITAL
Change in Working Capital INMB - INmune Bio, Inc.
10.4 M
LAST VALUE
131.99%
2 YEAR CAGR
94.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR